NCT00004688View on ClinicalTrials.gov

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 1996

Study Completion Date

July 31, 1998

Conditions
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed GliomasGlioblastoma MultiformeRecurrent Brain Tumor
Interventions
DRUG

carmustine

DRUG

mercaptopurine

DRUG

streptozocin

All Listed Sponsors
lead

Emory University

OTHER